TGTX Average Annual Return 10 Years

Growth of $10,000.00
Without Dividends Reinvested Into TGTX

Also see:
• TGTX stock yearly return 2014
• TGTX stock yearly return 2015
• TGTX stock yearly return 2016
• TGTX stock yearly return 2017
• TGTX stock yearly return 2018
• TGTX stock yearly return 2019
• TGTX stock yearly return 2020
• TGTX stock yearly return 2021
• TGTX stock yearly return 2022
• TGTX stock yearly return 2023
• TGTX YTD return

Compare TGTX average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return

Start date:	12/05/2014
End date:	12/04/2024
Start price/share:	$13.80
End price/share:	$33.88
Dividends collected/share:	$0.00
Total return:	145.51%
TGTX Average Annual Return:	9.39%
Starting investment:	$10,000.00
Ending investment:	$24,546.51
Years:	10.01

TGTX average annual return is presented with the assumption of reinvestments of any dividends on ex-date.

TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. Co. is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. The TGTX average annual return 10 years is shown above.

The Average Annual Return on the TGTX average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether TGTX average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the TGTX average annual return calculation with any dividends reinvested as applicable (on ex-dates).

Quotes delayed 20 minutes

Free TGTX Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

10 Most Oversold Stocks in the S&P

10 Most Overbought Stocks in the S&P

10 ETFs With Stocks That Insiders Are Buying

10 ETFs With Most Upside To Analyst Targets

The DividendRank Top 25

Warren Buffett Dividend Stocks

10 Cheap Dividend Stocks Under $10

10 Energy Stocks You Can Buy Cheaper Than Insiders Did

10 Top DividendRank'ed Energy Stocks

The 10 Highest Yielding Preferred Stocks

The 15 Most Active Call & Put Options of the S&P 500 Components

Video: Don't Forget Dividends in Average Annual Return!

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

TG Therapeutics (TGTX) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

THAR Average Annual Return
THC Average Annual Return
THRD Average Annual Return
TIL Average Annual Return
TIVC Average Annual Return
TKNO Average Annual Return
TLIS Average Annual Return
TLPH Average Annual Return
TLRY Average Annual Return
TMCI Average Annual Return
More Healthcare companies »

★★★★ Based on a ranking of our entire coverage universe by highest ten year average annual return, TG Therapeutics (TGTX) ranks within the highest 50% of all stocks whose returns we have reviewed.

What has the average annual return been for TGTX over the past ten years?

✔️Accepted answer: The ten year TGTX average annual return has been 9.39%.

What start date was used in your TGTX average annual return calculation?

✔️Accepted answer: The start date was 12/05/2014.

What end date was used in your TGTX average annual return calculation?

✔️Accepted answer: The end date was 12/04/2024.

If I had invested $10,000 into TGTX ten years ago, how much would I have today?

✔️Accepted answer: Today, as of 12/04/2024, you would have $24,546.51.

What does that work out to on a total return basis?

✔️Accepted answer: The TGTX ten year total return ending 12/04/2024 works out to 145.51%.

TGTX Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2024, All Rights Reserved